RGCC (Research Genetic Cancer Centre)

RGCC (Research Genetic Cancer Centre) testing offers advanced, personalized insight into cancer at the cellular level. This specialized lab analysis evaluates circulating tumor cells, tumor behavior, and potential sensitivity to various therapies—including integrative and targeted treatments. At EHC Buffalo, RGCC testing may be used to help guide more individualized care plans, identify supportive therapies, and monitor response over time. By incorporating this innovative diagnostic tool, our team is able to take a more precise, data-driven approach to integrative oncology.